
Cassel Salpeter & Co.’s Q3 healthcare update points to disrupted NIH grant processing, FDA attrition, and tariffs as pressures on drug development and early-stage financing.
Human Research Relies on Accuracy, Honesty, Attention to Details, and Quick and Effective Response of the IRB






